Clinical trial · Observational
Cervical Carcinoma in Shatby University Hospital and Its Relation to Human Papilloma Virus
NCT05539274CI-TRIAL-00061189completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
incidence of detection of carcinogenic types of human papilloma virus in 60 cases of cervical cancer
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cervical Cancer | Malignant Cervical Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| human papilloma virus testing and genotyping in cervical cancer cases | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- cervical cancer group, control group
- interventionNames
- Diagnostic Test: human papilloma virus testing and genotyping in cervical cancer cases
Primary outcomes (1)
- measure
- Detection of human papilloma virus infections and genotyping using real time PCR
- timeFrame
- 10 days
Eligibility
Eligibility (as posted)
- Sex
- Female
Show eligibility criteria text
Inclusion Criteria: * cervical cancer Exclusion Criteria: * none
References
Publications (0)
Data not yet available
No reference posted for this study.